19 June 2013
Keywords: update, alkermes, acquire, reliant, 934m, deal, signed
Article | 01 April 2002
Alkermes has signed a definitive agreement to acquire fellow US firmReliant Pharmaceuticals in a stock deal valued at $934 million, based ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
1 April 2002
18 June 2013
© 2013 thepharmaletter.com